For citations:
Nekrasov A.A., Timoschenko E.S., Strongin L.G., Nekrasova T.A., Baranova A.A., Botova S.N., Timoschenko M.V., Yaroslavtseva M.A. The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study. Diabetes mellitus. 2019;22(4):348-357. (In Russ.) https://doi.org/10.14341/DM10099
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
